These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30840281)

  • 1. Correlations of the MiR-330 expression with the pathogenesis and prognosis of breast cancer.
    Zhang HL; Wang XX; Zhang F
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1584-1590. PubMed ID: 30840281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 as an indicator of aggressive phenotype in breast cancer.
    Ozgün A; Karagoz B; Bilgi O; Tuncel T; Baloglu H; Kandemir EG
    Onkologie; 2013; 36(3):115-8. PubMed ID: 23485999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer.
    Li J; Song ZJ; Wang YY; Yin Y; Liu Y; Nan X
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
    Song CG; Wu XY; Wang C; Fu FM; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and its clinical significance of miR-155 in human primary breast cancer].
    Zhu J; Hu XQ; Guo GL; Zhang Y; Wang OC; You J; Huang QD; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2010 Feb; 48(3):205-8. PubMed ID: 20388420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of miR-155 on formalin-fixed paraffin embedded tissues with invasiveness and prognosis of breast cancer].
    Song CG; Wu XY; Fu FM; Han ZH; Wang C; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1011-4. PubMed ID: 23302487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and significance of five types of miRNAs in breast cancer.
    Min W; Wang B; Li J; Han J; Zhao Y; Su W; Dai Z; Wang X; Ma Q
    Med Sci Monit Basic Res; 2014 Jul; 20():97-104. PubMed ID: 25047098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Expression Levels of Micro Ribonucleic Ccid-10b (miR-10b) and Micro Ribonucleic Acid-181b (miR-181b) with Gastric Cancer and Its Diagnostic Significance.
    Gao Y; Xu Z; Yuan F; Li M
    Med Sci Monit; 2018 Nov; 24():7988-7995. PubMed ID: 30403658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the relationship between miR-520g and the development of breast cancer.
    Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
    Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of microRNA-155 expression in human breast cancer.
    Chen J; Wang BC; Tang JH
    J Surg Oncol; 2012 Sep; 106(3):260-6. PubMed ID: 22105810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.
    Li M; Li Q; Yin Q; Wang Y; Shang JM; Wang LH
    Clin Transl Oncol; 2021 Apr; 23(4):709-717. PubMed ID: 33206330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of microRNA-145 expression is involved in the development and prognosis of breast cancer complicated by type 2 diabetes mellitus.
    Liu HT; Xu YT; Li HY; Zhao J; Zhai HY; Chen Y
    Int J Biol Markers; 2016 Dec; 31(4):e368-e374. PubMed ID: 27396353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.